Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oxaliplatin Regimen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00166465
What this trial is testing

Stage IV Colorectal CA ALIMTA

Who this might be right for
Locally Advanced Unresectable or Stage IV Colorectal Cancer
Mayo Clinic 200
Large-scale testing (Phase 3)Study completedNCT01571284
What this trial is testing

Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

Who this might be right for
Colorectal Cancer Metastatic
Sanofi 781
Large-scale testing (Phase 3)Not Yet RecruitingNCT07483684
What this trial is testing

A Clinical Study to Evaluate Injection TQB2102 for the Treatment of Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Progressed After Treatment With Oxaliplatin, Irinotecan and Fluoropyrimidine-Based Drugs

Who this might be right for
HER2 IHC3+ Advanced Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 142
Large-scale testing (Phase 3)Study completedNCT00068692
What this trial is testing

Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer

Who this might be right for
Rectal Mucinous AdenocarcinomaRectal Signet Ring Cell AdenocarcinomaRecurrent Rectal Carcinoma+8 more
National Cancer Institute (NCI) 225
Large-scale testing (Phase 3)UnknownNCT01092481
What this trial is testing

Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy

Who this might be right for
Colon Cancer
Samsung Medical Center 1,580
Not applicableNot Yet RecruitingNCT07325214
What this trial is testing

Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerBorderline Resectable Pancreatic CancerLocally Advanced Pancreatic Cancer
IMGT Co., Ltd. 360
Early research (Phase 1)Study completedNCT00003427
What this trial is testing

Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

Who this might be right for
Anal CancerColorectal CancerEsophageal Cancer+7 more
Memorial Sloan Kettering Cancer Center 36
Not applicableUnknownNCT02002195
What this trial is testing

Modified Folinic Acid-Fluorouracil-Oxaliplatin Regimen + Capecitabine for Elderly With Metastatic Gastric Cancer

Who this might be right for
Metastatic Gastric Cancer
International Group of Endovascular Oncology 47
Not applicableEnded earlyNCT00777192
What this trial is testing

Longitudinal Study of Symptoms in Colorectal Cancer

Who this might be right for
Colorectal Cancer
M.D. Anderson Cancer Center 509
Not applicableStudy completedNCT00897819
What this trial is testing

Studying DNA and Outcome in Patients With Advanced Colorectal Cancer Treated With Fluorouracil and Oxaliplatin With or Without Bevacizumab on Clinial Trial E-3200

Who this might be right for
Colorectal Cancer
ECOG-ACRIN Cancer Research Group 350
Large-scale testing (Phase 3)UnknownNCT02025036
What this trial is testing

Chemoradiotherapy of Capecitabine With or Without Oxaliplatin Versus Cisplatin-5-FU for Esophageal Squamous Cancer

Who this might be right for
Stage III Esophageal Squamous Cell CarcinomaStage II Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Henan University of Science and Technology 249
Testing effectiveness (Phase 2)Looking for participantsNCT07504471
What this trial is testing

Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases

Who this might be right for
Pancreatic NeoplasmsHepatic Metastasis of Pancreatic Cancer
Ruijin Hospital 50
Large-scale testing (Phase 3)UnknownNCT04393584
What this trial is testing

FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma

Who this might be right for
Stomach NeoplasmsGastrointestinal NeoplasmsDocetaxel+3 more
Blokhin's Russian Cancer Research Center 538
Testing effectiveness (Phase 2)Looking for participantsNCT05557578
What this trial is testing

GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence

Who this might be right for
Intrahepatic Cholangiocarcinoma
Zhejiang Cancer Hospital 20
Early research (Phase 1)Looking for participantsNCT04361708
What this trial is testing

Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies

Who this might be right for
Pancreatic AdenocarcinomaGastroesophageal Junction AdenocarcinomaAdenocarcinoma
University of Chicago 54
Not applicableNot Yet RecruitingNCT06823050
What this trial is testing

A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC

Who this might be right for
Hepatocellular Carcinoma
Xuhua Duan 59
Testing effectiveness (Phase 2)UnknownNCT04310176
What this trial is testing

Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer

Who this might be right for
Ras-mutated Metastatic Colorectal Cancer
National Cancer Institute, Naples 200
Large-scale testing (Phase 3)UnknownNCT01583361
What this trial is testing

SOX Regimen as Neoadjuvant Chemotherapy for AJCC Stage II-III Gastric Cancer

Who this might be right for
Gastric Adenocarcinoma
Lin Chen 772
Large-scale testing (Phase 3)Not Yet RecruitingNCT07449780
What this trial is testing

AK104 (SC) in Combination With Oxaliplatin and Capecitabine (XELOX) Versus AK104 (IV) in Combination With XELOX in Participants With Unresectable Locally Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric / Gastroesophageal Junction Adenocarcinoma
Akeso 422
Large-scale testing (Phase 3)Study completedNCT00145314
What this trial is testing

FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
The Nordic Colorectal Cancer Biomodulation Group 571
Next Page